[1]ÁÖÏþΰ,µËÃ÷Ò¢,ËïÃá,µÈ.»ùÓÚÑõ»¯Ó¦¼¤ºÍÑ×Ö¢½éÖÊ·´Ó¦Ì½ÌÖ²ÝľéØÌáÈ¡Îï¶Ô¼±ÐÔÄÔȱѪ×éÖ¯±£»¤×÷ÓõĻúÖÆÑо¿[J].×äÖÐÓëÉñ¾­¼²²¡ÔÓÖ¾,2022,29(04):317-323.[doi:10.3969/j.issn.1007-0478.2022.04.003]
¡¡Lin Xiaowei,Deng Mingyao,Sun Mian,et al.Protective effect and mechanism of Melilotus officinalis extracts on acute cerebral ischemia based on oxidative stress and inflammatory mediator responses[J].Stroke and Nervous Diseases,2022,29(04):317-323.[doi:10.3969/j.issn.1007-0478.2022.04.003]
µã»÷¸´ÖÆ

»ùÓÚÑõ»¯Ó¦¼¤ºÍÑ×Ö¢½éÖÊ·´Ó¦Ì½ÌÖ²ÝľéØÌáÈ¡Îï¶Ô¼±ÐÔÄÔȱѪ×éÖ¯±£»¤×÷ÓõĻúÖÆÑо¿()
·ÖÏíµ½£º

¡¶×äÖÐÓëÉñ¾­¼²²¡¡·ÔÓÖ¾[ISSN:1007-0478/CN:42-1402/R]

¾í:
µÚ29¾í
ÆÚÊý:
2022Äê04ÆÚ
Ò³Âë:
317-323
À¸Ä¿:
ÂÛÖø
³ö°æÈÕÆÚ:
2022-09-10

ÎÄÕÂÐÅÏ¢/Info

Title:
Protective effect and mechanism of Melilotus officinalis extracts on acute cerebral ischemia based on oxidative stress and inflammatory mediator responses
ÎÄÕ±àºÅ:
1007-0478(2022)04-0317-07
×÷Õß:
ÁÖÏþΰµËÃ÷Ò¢ËïÃáÁÖÑÅÃ÷
572000 º£ÄÏÊ¡ÈýÑÇÊÐÈËÃñÒ½Ôº¼±Õï¿Æ
Author(s):
Lin Xiaowei Deng Mingyao Sun Mian et al.
Department of Emergency, Sanya People's Hospital, Sanya Hainan 572000
¹Ø¼ü´Ê:
²ÝľéØÄÔȱѪÑõ»¯Ó¦¼¤Ï¸°ûÒò×Óϸ°ûµòÍö
Keywords:
Melilotus officinalis Cerebral ischemia Oxidative stress Cytokines Apoptosis
·ÖÀàºÅ:
R743.3
DOI:
10.3969/j.issn.1007-0478.2022.04.003
ÎÄÏ×±êÖ¾Âë:
A
ÕªÒª:
Ä¿µÄ ÆÀ¹À²ÝľéØÌáÈ¡Îï¶Ô¼±ÐÔÄÔȱѪ×éÖ¯µÄ±£»¤×÷Óü°±£»¤»úÖÆ¡£·½·¨ ½«50Ö»ÐÛÐÔWistar´óÊóËæ»ú·ÖΪ¼ÙÊÖÊõ×顢ģÐÍ×é¡¢²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×é,ÿ×é¸÷10Ö»; ³ý¼ÙÊÖÊõ×éÍâ,ÆäÓà¸÷×é´óÊóͨ¹ý¸ÄÁ¼Longa·¨½¨Á¢¼±ÐÔÄÔȱѪģÐÍ; ¶Ô²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éÄÔȱѪ´óÊó·Ö±ð¸øÓè100¡¢250¡¢500 mg/kg²ÝľéØÖÎÁÆ,¼ÙÊÖÊõ×é¼°Ä£ÐÍ×鏸ÓèµÈÁ¿ÉúÀíÑÎË®; ²ÉÓÃ2,3,5 ÂÈ»¯Èý±½»ùËĵªßòȾɫ·¨(Triphenyltetrazolium chloride,TTC)¼ì²â´óÊóÄÔ¹£ËÀÌå»ý; ²ÉÓÃLongaÆÀ·Ö·¨ÆÀ¹ÀÉñ¾­¹¦ÄÜËðÉËÆÀ·Ö; ²ÉÓ÷ÅÉäÃâÒ߲ⶨ·¨¼ì²âѪ½¬6-ͪ-ǰÁÐËØF1a(6-keto-prostaglandin F1a,6-keto-PGF1a)¼°ÑªË¨ËØB2(Thromboxane B2,TXB2)ˮƽ; ²ÉÓÃøÁªÃâÒßÎü¸½ÊµÑé(Enzyme linked immunosorbent assay,ELISA)ÊÔ¼ÁºÐ¼ì²âÖ×Áö»µËÀÒò×Óa(Tumor necrosis factor-alpha,TNF-a)¡¢°×ϸ°û½éËØ10(Interleukin-10,IL-10)ˮƽ; ²ÉÓ÷ֹâ¹â¶È¼ÆÆÀ¹À³¬Ñõ»¯ÎïÆç»¯Ã¸(Superoxidedismutase,SOD)¼°¹Èë׸ÊëĹýÑõ»¯Îïø(Glutatheione peroxidase,GSH-Px)»îÐÔ; ²ÉÓÃԭλĩ¶ËµòÍö·¨(TdT-mediated dUTP nick-end labeling, TUNEL)¼ì²âÄÔ×éÖ¯Éñ¾­ÔªµòÍöÇé¿ö; ²ÉÓõ°°×ÖÊÓ¡¼£·¨(Western blot)¼ì²âBÁܰÍϸ°ûÁö-2»ùÒò(B-cell lymphoma-2,Bcl-2)¼°Bcl-2-Ïà¹ØX(Bcl-2-Associated X,Bax)µ°°×Ïà¶Ô±í´ïˮƽ¡£½á¹û ÓëÄ£ÐÍ×é±È½Ï,²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éµÄÄÔ¹£ËÀÌå»ýºÍÉñ¾­¹¦ÄÜȱËðÆÀ·ÖÏÔÖø½µµÍ(P<0.05),ÇÒËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¸÷×é´óÊóÄÔ¹£ËÀÌå»ý¼°Éñ¾­¹¦ÄÜȱËðÆÀ·ÖÖð½¥½µµÍ(P<0.05)¡£ÓëÄ£ÐÍ×é±È½Ï,²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éѪ½¬6-keto-PGF1aˮƽÏÔÖøÔö¸ß(P<0.05),Ѫ½¬TXB2ˮƽÏÔÖø½µµÍ(P<0.05),ÇÒËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¸÷×é´óÊóѪ½¬6-keto-PGF1aˮƽÖð½¥Ôö¸ß(P<0.05)¡¢Ñª½¬TXB2ˮƽÖð½¥½µµÍ(P<0.05)¡£ÓëÄ£ÐÍ×é±È½Ï,²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éTNF-aˮƽÏÔÖø½µµÍ(P<0.05),IL-10,SOD,GSH-PXˮƽÏÔÖøÉý¸ß(P<0.05),ÇÒËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¸÷×é´óÊóTNF-aˮƽÖð½¥½µµÍ(P<0.05)¡¢IL-10,SOD,GSH-PXˮƽÖð½¥Éý¸ß(P<0.05)¡£ÓëÄ£ÐÍ×é±È½Ï,²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éϸ°ûµòÍöÂÊÏÔÖø½µµÍ(P<0.05),ÇÒËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¸÷×é´óÊóϸ°ûµòÍöÂÊÖð½¥½µµÍ(P<0.05)¡£ÓëÄ£ÐÍ×é±È½Ï,²ÝÄ¾éØµÍ¡¢ÖС¢¸ß¼ÁÁ¿×éBcl-2µ°°×Ïà¶Ô±í´ïˮƽÏÔÖøÉý¸ß(P<0.05),Baxµ°°×Ïà¶Ô±í´ïˮƽÏÔÖø½µµÍ(P<0.05),ÇÒËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¸÷×é´óÊóBcl-2µ°°×Ïà¶Ô±í´ïˮƽÖð½¥Éý¸ß¡¢Baxµ°°×Ïà¶Ô±í´ïˮƽÖð½¥½µµÍ(P<0.05)¡£½áÂÛ ²ÝÄ¾éØ¿Éͨ¹ý¼õÉÙÄÔѪ˨Ðγɡ¢Ñõ»¯Ó¦¼¤ºÍÑ×Ö¢½éÖÊÀ´ÒÖÖÆ´óÊóÄÔȱѪ×é֯ϸ°ûµòÍö,¶ÔÄÔȱѪ×éÖ¯¾ßÓб£»¤×÷ÓÃ,ÇÒÑо¿·¢ÏÖËæ×ŲÝľ騏øÒ©¼ÁÁ¿µÄÔö¼Ó,¶ÔÄÔȱѪ×éÖ¯µÄ±£»¤×÷Óøü¼ÓÃ÷ÏÔ¡£
Abstract:
ObjectiveTo evaluate the protective effect and mechanism of Melilotus officinalis extracts on acute cerebral ischemia based on oxidative stress and inflammatory mediator responses.Methods Fifty male Wistar rats were randomly divided into sham group, model group, and low-dose, medium-dose, high-dose Melilotus officinalis groups, with 10 rats in each group. Acute cerebral ischemia models were established by modified Longa method. Rats in the low-dose, medium-dose, high-dose groups were treated with 100 mg/kg, 250 mg/kg, or 500 mg/kg Melilotus officinalis extracts respectively. Rats in sham operation group and model group were treated with the same dose of normal saline. The cerebral infarction volume was measured by TTC method and neurological deficit score was estimated by Longa scoring method. 6-Keto-PGF1¦Á and TXB2 concentrations in plasma were estimated by radioimmunoassay. TNF-¦Á and IL-10 concentrations in plasma were estimated by ELISA. The activity of SOD and GSH-Px were estimated by spectrophotometer. The apoptosis of ischemic neurons in cerebral infarction tissues was detected by TUNEL. The expression of Bcl-2 and Bax was detected by Western blot.Results Compared with the model group, the infarct volume, neurological deficit score, TXB2 concentration in plasma, the level of TNF-¦Á, apoptosis rate and Bax expression were significantly decreased in low-dose, medium-dose, high-dose Melilotus officinalis treatment groups(P<0.05)in a dose-dependent manner. However, 6-Keto-PGF1¦Á concentration in plasma, the levels of IL-10,SOD, GSH-PXand Bcl-2 were significantly increased(P<0.05)in Melilotus officinalis groups in a dose-dependent way.Conclusion Melilotus officinalis ameliorates apoptosis of brain tissues in cerebral ischemic rats by decreasing cerebral thrombosis, oxidative stress, and inflammatory mediator responses. Melilotus officinalis has a protective effect on ischemic brain tissue in a dose-dependent manner.

²Î¿¼ÎÄÏ×/References:

[1] Benjamin EJ, Muntner P, Alonso AA, et al. Heart disease and stroke statistics-2019 update a report from the American heart association[J]. Circulation, 2019, 139(10): E56-E528.
[2] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(1204): 1145-1158.
[3] Wu C, Zhao X, Zhang X, et al. Effect of ginkgo biloba extract on apoptosis of brain tissues in rats with acute cerebral infarction and related gene expression[J]. Genet Mol Res, 2015, 14(2): 6387-6394.
[4] Gonzalez-Rodriguez PJ, Xiong F, Li Y, et al. Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors[J]. Neurobiol Dis, 2014, 65: 172-179.
[5] Savarese G, Savonitto S, Lund LH, et al. Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients[J]. Eur Heart J Cardiovasc Pharmacother, 2016, 2(4): 218-228.
[6] Signorelli SS, Platania I, Tomasello SD, et al. Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review[J]. Int J Environ Res Public Health, 2020, 17(16): 5840.
[7] Menkovic' N, SavikinK, Tasic'S, et al. Ethnobotanical study on traditional uses of wild medicinal plants in Prokletije Mountains(Montenegro)[J]. J Ethnopharmacol, 2011, 133(1): 97-107.
[8] Ple ÿðþ ‰D ca-Manea L, Pârvu AE, Pârvu M, et al. Effects of melilotus officinalis on acute inflammation[J]. Phytother Res, 2002, 16(4): 316-319.
[9] Liu YT, Gong PH, Xiao FQ, et al. Chemical constituents and antioxidant, Anti-Inflammatory and Anti-Tumor activities of melilotus officinalis(Linn.)pall[J]. Molecules, 2018, 23(2): 271.
[10] Zhang J, Di H, Luo K, et al. Coumarin content, morphological variation, and molecular phylogenetics of melilotus[J]. Molecules, 2018, 23(4): 810.
[11] Ðíº£½­,ËïͬÎÄ,ÕÔ´ºÁá,µÈ.µ¤²Îͪ¢òA¶ÔÄÔȱѪÔÙ¹à×¢ËðÉË´óÊóÄԵı£»¤×÷ÓÃ[J].ÖйúҽԺҩѧÔÓÖ¾,2013,33(16):1334-1337.
[12] ºÂºì,Àî·½,ÍõÖ¾,µÈ.Òþµ¤²Îͪ¶ÔÄÔȱѪÔÙ¹à×¢ËðÉËÉñ¾­ÔªÏ¸°ûµòÍöµÄ×÷ÓÃ[J].ÖйúÁÙ´²Ò©ÀíѧÔÓÖ¾,2021,37(3):250-254.
[13] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-91.
[14] ÑôÏþÇç,ÌÆÑ©Ã·,ËÕœ®ä¿,µÈ.½Ê¹ÉÀ¶×ÜÜÕ¶ÔÂýÐÔÄÔȱѪ´óÊóº£ÂíÉñ¾­ÔªµÄ±£»¤×÷Óü°Æä»úÖÆÑо¿[J].ÖйúÏÖ´úÓ¦ÓÃҩѧ,2019,36(12):1487-1491.
[15] Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide Population-Based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771.
[16] ÁõÀÚ,ÎâÒ»·É.ĵ¾£ÜÕ¶Ô¼±ÐÔÄÔȱѪ´óÊó´óÄÔÎÆ×´Æ¤ÖÊnNOSÃâÒß±í´ïµÄÓ°Ïì[J].ÖйúÃâÒßѧÔÓÖ¾,2020,36(23):2855-2860.
[17] Zhao QS, Li W, Li D, et al. Clinical treatment efficiency of mechanical thrombectomy combined with rhPro-UK thrombolysis for acute moderate/severe cerebral infarction[J]. Eur Rev Med Pharmacol Sci, 2018, 22(17): 5740-5746.
[18] Zhou Z, Lu J, Liu WW, et al. Advances in stroke pharmacology[J]. Pharmacol Ther, 2018, 191: 23-42.
[19] Íõ¼Ñ,Ñî¿¡Çä,ÓàÀö¾ê,µÈ.NF-¦ÊBÒÖÖÆ¼ÁPDTC±£»¤È«ÄÔȱѪ/ÔÙ¹à×¢´óÊóº£ÂíËðÉË»úÖÆÉæ¼°COX2-PGI2/TXA2ͨ·µÄ³õ̽[J].ÖйúÒ©Àíѧͨ±¨,2014(6):782-786.
[20] Ahmed MA, El ME, Ahmed AA. Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats[J]. Life Sci, 2014, 110(2): 61-69.
[21] Ueba Y, Aratake T, Onodera KI, et al. Attenuation of zinc-enhanced inflammatory M1 phenotype of microglia by peridinin protects against short-term spatial-memory impairment following cerebral ischemia in mice[J]. Biochem Biophys Res Commun, 2018, 507(1/4): 476-483.
[22] Gaire BP, Bae YJ, Choi JW. S1P(1)regulates M1/M2 polarization toward brain injury after transient focal cerebral ischemia[J]. Biomol Ther(Seoul), 2019, 27(6): 522-529.
[23] ½¯ÏþÁá,ÍõÑô,¹ùÐÂÁá,µÈ.LncRNA ANRIL¸ÉÈÅmiR-153²¢½éµ¼NF-¦ÊB P65µÄºËתλÓÕµ¼ÄÔȱѪÔÙ¹àעСÊóÄÔ×éÖ¯ËðÉ˺Íϸ°ûµòÍöÒÔ¼°Ñõ»¯Ó¦¼¤[J].ÖйúÃâÒßѧÔÓÖ¾,2021,37(2):139-144.
[24] ·®ÎÄÏã.ȱѪÐÔÄÔ×äÖеĻúÖÆÑо¿½øÕ¹[J].ÖйúÒ©¿Æ´óѧѧ±¨,2018,49(6):751-759.
[25] »ÆÓÅ,³Âº£ÔÆ,ºÎ³¬Ã÷,µÈ.¶¡±½Ìª¶Ô´óÊóÄÔȱѪÔÙ¹à×¢ËðÉËÖÐÑõ»¯Ó¦¼¤Ñ×ÐÔͨ·µÄÓ°Ïì[J].Î÷°²½»Í¨´óѧѧ±¨(ҽѧ°æ),2020,41(2):201-205.
[26] Hollville E, Romero SE, Deshmukh M. Apoptotic cell death regulation in neurons[J]. FEBS J, 2019, 286(17): 3276-3298.
[27] Ashkenazi A, Fairbrother WJ, Leverson JD, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nat Rev Drug Discov, 2017, 16(4): 273-284.
[28] Siddiqui WA, Ahad A, Ahsan H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update[J]. Arch Toxicol, 2015, 89(3): 289-317.
[29] Óáî£,×£ÃÀÕä,Áõٻݼ,µÈ.ÇåÄÔÒæÔªÌÀ¶ÔÄÔȱѪËðÉË´óÊóȱѪ²àƤÖÊÇøÉñ¾­Ï¸°ûµòÍö¼°µòÍöÏà¹Øµ°°×Bcl-2¡¢Bax±í´ïµÄÓ°Ïì[J].ÖйúÀÏÄêѧÔÓÖ¾,2021,41(4):825-830.

ÏàËÆÎÄÏ×/References:

[1]²ÜÑôÔÂ,ÖìÓêá°.ÄÔȱѪºó´¦ÀíÓëPI3K/AktÐźÅתµ¼Í¨Â·µÄÑо¿½øÕ¹[J].×äÖÐÓëÉñ¾­¼²²¡ÔÓÖ¾,2015,22(03):192.
[2]Æë¾ü,Àî·å.ȱѪÔÙ¹à×¢ÄÔËðÉË»úÖÆ¼°ÖÎÁƽøÕ¹[J].×äÖÐÓëÉñ¾­¼²²¡ÔÓÖ¾,2015,22(02):120.

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿:2018Ä꺣ÄÏÊ¡ÎÀÉú¼ÆÉúÐÐÒµ¿ÆÑÐÏîÄ¿(1802330169A2001)
¸üÐÂÈÕÆÚ/Last Update: 2022-09-10